Nomen | Ibutamoren mesylate |
Cas numerum | 159752-10-0 |
MOLECULA | C28h40n4o8s2 |
Pondus | 624,77 |
Einecs numerum | 1308068-626-2 |
Point liquescens | 164-170 ° C |
Solubility | H2O: Solutum5MG / ml, patet |
Repono condicionem | 2-8 ° C |
Forma | Pulverem |
Colo | Alba ad beige |
Stipare | PE lapides sacculi + Aluminium |
MK-677;2-Amino-N-[(1R)-2-[1,2-dihydro-1-(methylsulfonyl)spiro[3H-indole-3,4'-piperidin]-1'-yl]-2-oxo-1-[(phenylmethoxy)methyl]ethyl]-2-methylpropanamidemethanesulfon comedit; mk677 (Ibutamorenmesylate); MK, DCLXXVII; Crescendo; MK0677; MK-DCLXXVII, MK0677; MK677; MK677; C S-MCDII; mk677mk6777ibutamoren, mk677mk67777ibutamoren, WNNHE_LUCY (at) 163.com, MK677, MK677
Descriptio
Ibramolen Mesylate est a medicamento quod acts ut potens, viva voce potentia, augmentum-stimulating hormone secretio, mimicking actio GH ad stimulate endogenous Hormones.
Munus
Ibramolen Mesylate iam ostensum est ad augendam release et productio de persistently auctum plasma campester of quidam hormones inter GH et insulin-ut incrementum factor I (IGF-I), sed non afficit cortisol campester. Potential treatments currently in progressionem reducere campester horum hormones, ut in filios vel senes cum incrementum hormone defectus, et humana studiis ostensum est auctus musculus et os mineralibus, faciens auctus musculus et os mineralibus maior adultis. Etiam alters in metabolismi corporis adipem, ita ut habeatis applications in curatio ex dolore magna.
In Vivo Studies
Ibutamoren Mesylate (mg V / kg / die) results in statistically significant auget corpus pondus lucrum et crescit Serum IGF-I and GH campester in canibus. Ibutamoren Mesylate results in nullo significant incremento in CSF IGF-I aut GH campester in diebus VII vel XV de studiis. Praetreating mures cum GH cuneos activation horum neurons ab Ibutamoren Mesylate (L μg, IP). In knockout mures, tum GH et Octrotide deficient inhibere Ibutamoren Mesylate activation de arcuate neurons. Longos oris administratione MK-DCLXXVII est consociata cum significant crescit in GH et IGF-i campester, quae sunt ad durationem curatio. Et GH Profile sequenti MK-DCLXXVII Administration est episodic crescit super imperium. MK-DCLXXVII significantly crescit apicem GH concentratione post oralis administratione. Mk-DCLXXVII est potens Gh Secretagogue quod inducit immediatam, magna, diu perpetuam incremento in GH campester cum administrato viva voce vel IV